Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-22

Clinical Trial Update: Evaluation of the Effect of Narrowband UVB Versus Methotrexate on Serum Chitotriosidase Level in Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating narrowband UVB compared with methotrexate on serum chitotriosidase levels in psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHOTREXATE (METHOTREXATE)
  • Narrowband UVB

Snippet

Sponsor: Aswan University Hospital | Conditions: Psoriasis | Phase 4 | Status: UNKNOWN